Skip to content

MediXall Group, Inc.: 10-Q filed 2022-08-23

What MediXall Group, Inc. reported in its quarterly report filed 2022-08-23 (fiscal Q2 2022): 28 published measures, 83 facts as tagged in accession 0001553350-22-000715.

This filing

Form
10-Q (quarterly report)
Filed
2022-08-23
Fiscal period
fiscal Q2 2022
Accession
0001553350-22-000715 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MediXall Group, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-06-301,160,921USD
At 2021-12-311,131,581USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-06-302,925,366USD
At 2021-12-311,471,703USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-06-30-1,764,445USD
At 2022-03-31-675,495USD
At 2021-12-31-340,122USD
At 2021-06-30363,137USD
At 2021-03-311,016,478USD
At 2020-12-31381,904USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,553,994USD91
2022-01-01 to 2022-06-30-3,964,096USD181
2022-01-01 to 2022-03-31-2,410,102USD90
2021-04-01 to 2021-06-30-1,659,216USD91
2021-01-01 to 2021-06-30-2,991,517USD181
2021-01-01 to 2021-03-31-1,332,301USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-2,064,883USD181
2021-01-01 to 2021-06-30-2,801,943USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-04-01 to 2022-06-3010,352USD91
2022-01-01 to 2022-06-3018,259USD181
2021-04-01 to 2021-06-30166,642USD91
2021-01-01 to 2021-06-30169,913USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-06-302,176,990USD181
2021-01-01 to 2021-06-302,294,375USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-06-30-1,680USD181
2021-01-01 to 2021-06-30-12,840USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-06-30-29,746,486USD
At 2021-12-31-25,782,390USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-04-01 to 2022-06-30116,151,261shares91
2022-01-01 to 2022-06-30115,392,749shares181
2021-04-01 to 2021-06-30102,075,557shares91
2021-01-01 to 2021-06-30101,177,844shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-04-01 to 2022-06-30116,151,261shares91
2022-01-01 to 2022-06-30115,392,749shares181
2021-04-01 to 2021-06-30102,075,557shares91
2021-01-01 to 2021-06-30101,177,844shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.01USD/shares91
2022-01-01 to 2022-06-30-0.04USD/shares181
2021-04-01 to 2021-06-30-0.02USD/shares91
2021-01-01 to 2021-06-30-0.03USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-0.01USD/shares91
2022-01-01 to 2022-06-30-0.04USD/shares181
2021-04-01 to 2021-06-30-0.02USD/shares91
2021-01-01 to 2021-06-30-0.03USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2022-04-01 to 2022-06-300USD91
2022-01-01 to 2022-06-300USD181
2021-04-01 to 2021-06-300USD91
2021-01-01 to 2021-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-06-3021,376USD
At 2021-12-3123,376USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-06-30190,929USD
At 2021-12-31342,945USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-06-301,344,376USD
At 2021-12-311,225,330USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-06-30219,142USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-04-01 to 2022-06-301,564,346USD91
2022-01-01 to 2022-06-303,982,355USD181
2021-04-01 to 2021-06-301,825,858USD91
2021-01-01 to 2021-06-303,161,430USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-06-30117,235,039shares
At 2021-12-31110,864,595shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-06-30173,845USD
At 2021-12-3163,418USD
At 2021-06-30125,354USD
At 2020-12-31645,762USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-06-3027,860,632USD
At 2021-12-3125,327,230USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-06-30278,070USD
At 2021-12-31313,856USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-06-30451,404USD
At 2021-12-31451,404USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,553,994USD91
2022-01-01 to 2022-06-30-3,964,096USD181
2021-04-01 to 2021-06-30-1,659,216USD91
2021-01-01 to 2021-06-30-2,991,517USD181

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2022-04-01 to 2022-06-30-1,627,643USD91
2022-01-01 to 2022-06-30-4,110,584USD181
2021-04-01 to 2021-06-30-1,718,903USD91
2021-01-01 to 2021-06-30-3,098,173USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-01-01 to 2022-06-303,680USD181
2021-01-01 to 2021-06-302,840USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2022-01-01 to 2022-06-30760,500USD181
2021-01-01 to 2021-06-30949,375USD181

Inspect the source

Entity
MediXall Group, Inc. / CIK 0001601280
Captured
2026-09-21T17:20:21.643Z
SEC response SHA-256
b6322b58d999c8a74b96274fe9d2bf7196a7223cedbe45a09c2d28d5c34a5827

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001601280.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))